Enhancing therapeutic outcomes with artificial intelligence for HR-positive, HER2-negative metastatic breast cancer.
Saved in:
| Title: | Enhancing therapeutic outcomes with artificial intelligence for HR-positive, HER2-negative metastatic breast cancer. |
|---|---|
| Authors: | Gomez Marti JL; Northwell Health, New Hyde Park, NY, USA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Michaels E; Department of Medical Oncology, Mass General Brigham Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Nasrazadani A; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wander SA; Department of Medical Oncology, Mass General Brigham Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Brufsky AM; Department of Medical Oncology, University of Pittsburgh, Pittsburgh, PA, USA. Electronic address: brufskyam@upmc.edu. |
| Source: | Cancer cell [Cancer Cell] 2026 Feb 09; Vol. 44 (2), pp. 254-256. |
| Publication Type: | Journal Article; Comment |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1878-3686 |
|---|---|
| DOI: | 10.1016/j.ccell.2026.01.004 |
